VMD
Viemed HealthcareANasdaq / Health Care Equipment & Services
Last Price
At close
2026-07-22
Current thesis
Strong Q1 growth, positive free cash flow, debt reduction, buybacks, and rapid PAP/resupply expansion support a constructive operating trajectory. The updated guide provides measurable validation points [#SEC-8K-2026-05-05].
Posture
Constructive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.2.
What can break
A director and chief medical officer sold 10,000 shares at $11.72 on June 25, 2026 [#SEC-FORM4-2026-06-26].
Momentum
85
Value
65
Sentiment
54
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $12.00 · Bull $15.00 · Bear $8.50
Data freshness
Prices
As of 2026-07-22
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-22 • Model: HYBRID_IC_RP
AI Memo
As of 2026-07-21 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-22
Investment thesis
As of 2026-07-22
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $11.00
Why
Momentum85 · Δ7d +5.0
Value65 · Δ7d -0.2
Sentiment54 · Δ7d +12.6
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Value · See fundamentals
Momentum
85
26% active weight
Current posture
7d trendFlat
Δ7d
+5.0
Δ21d
+6.8
Value
65
39% active weight
Current posture
7d trendFlat
Δ7d
-0.2
Δ21d
+0.0
Sentiment
54
34% active weight
Current posture
7d trendImproving
Δ7d
+12.6
Δ21d
+7.2
Why this grade
Composite grade A. Momentum 85.2 / Value 65.0 / Sentiment 53.8
Fundamentals (TTM)As of 2026-07-20
Fundamentals (TTM)
As of 2026-07-20
Market Cap
$458.89M
Beta
1.27
Shares Out
38.34M
P/E (TTM)
21.9
P/S (TTM)
1.08
P/FCF (TTM)
51.26
Rev YoY
+27.5%
EPS YoY
+1.1%
Gross Margin
+57.0%
Op Margin
+8.3%
Net Debt
$2.45M
Current Ratio
1.22
As of 2026-07-22 • Updated nightlySource: Internal modelMethodology